Omega-3 Polyunsaturated Fatty Acids (PUFAs) – A Global Market Overview
Global Omega-3 Polyunsaturated Fatty Acids (PUFAs) Market Trends and Outlook
Omega-3 Polyunsaturated Fatty Acids (PUFAs) are widely recognized for their considerable health benefits. They play a crucial role in promoting cardiovascular health and are also associated with protective effects against a variety of health conditions, including cancer, birth defects, diabetes, arthritis, cognitive decline, depression, and several others. These essential fatty acids are not produced by the body in sufficient quantities and must be obtained through diet or supplements. Historically, fish oils have been the primary source for extracting Omega-3 fatty acids, particularly the long-chain varieties like EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid). However, in recent years, attention has increasingly turned toward alternative sources such as krill oil, squid oil, and oils derived from microalgae. Among these, microalgae have emerged as a particularly promising and sustainable source.
The global Omega-3 PUFA ingredients market faced a tumultuous year in 2023. The market experienced pronounced volatility, largely due to significant disruptions in supply and mounting economic challenges. One of the key contributing factors was a marked decline in fish oil production, especially in Peru, which is among the world's leading suppliers. This decline was brought on by a combination of environmental and regulatory factors. The El Nino phenomenon caused shifts in ocean temperatures and altered fish migration patterns, which resulted in lower fish populations. In response, the Peruvian government not only canceled a fishing season but also imposed reduced quotas for allowable catch. These developments, coupled with broader issues such as disruptions in global supply chains, shortages of raw materials, and escalating transportation costs, severely curtailed the availability of Omega-3 ingredients and triggered a significant rise in prices.
Moving into 2024, market conditions began to stabilize. There was an improvement in fishing quotas and a recovery in fish oil production, particularly in regions affected during the previous year. These developments helped to normalize both supply and pricing levels across the market. As a result, global Omega-3 demand registered a growth of 3.8%. However, with prices softening from the elevated levels of 2023, the market's overall value declined by 9.7%, settling at US$2.23 billion. Continued interest in the health benefits of Omega-3s, combined with increasing consumer awareness and innovation in sourcing and product formulation, is expected to support ongoing growth. By the year 2030, global Omega-3 PUFAs demand is projected to reach US$2.54 billion with a compound annual growth rate (CAGR) of 2.4% over the forecast period spanning 2024 to 2030.
Omega-3 Polyunsaturated Fatty Acids (PUFAs) Regional Market Analysis
The report reviews, analyzes and projects the Omega-3 PUFAs market for global and the regional markets including North America, Europe, Asia-Pacific, South America and Rest of World for the period 2021-2030 in terms of volume (metric tons) as well as value (USD). Asia-Pacific region leads the global Omega-3 PUFAs volume market with a share of 41.7% in 2024 and is further projected to record the world fastest CAGR of 5.5% during 2024-2030 to reach 91 thousand metric tons by 2030. In terms of value, North America and Asia-Pacific led the global market with shares of 33.5% and 33.2% respectively in 2024. However, demand for Omega-3 PUFAs in North America is projected to sustain the slowest CAGR of 2.2% during the similar period.
Omega-3 Polyunsaturated Fatty Acids (PUFAs) Market Analysis by Raw Material Source
Omega-3 Polyunsaturated Fatty Acid (PUFAs) ingredients analyzed in this study include Omega-3 EPA and DHA from marine sources including fish oils, krill oils and squid oils; and algal sources. Marine oils constitute the largest raw material source for Omega-3 PUFAs globally, cornering a volume share estimated at 95% in 2024, valued at US$1.8 billion. However, algal oils are likely to emerge as the faster growing source for Omega-3 PUFAs, reaching a projected US$531.5 million in 2030 by registering a CAGR of 6.6% between 2024 and 2030.
Omega-3 Polyunsaturated Fatty Acids (PUFAs) Market Analysis by End-use Application
End use applications of Omega-3PUFAs covered in this report include dietary supplements, food & beverages, animal nutrition including aqua feed and pet food, infant nutrition, pharmaceuticals and clinical nutrition. In terms of volume, dietary supplements and animal nutrition are the two largest applications for Omega-3s globally cornering shares of 57% and 22.2% respectively in 2024. Dietary supplements again lead the value market for Omega-3 globally with US$777 million, followed by infant nutrition and pharmaceuticals in 2024. Demand for Omega-3 PUFAs in the global infant nutrition sector is projected to post the fastest 2024-2030 CAGR of 6.3% in terms of volume, reaching 20 thousand metric tons by 2030.
Omega-3 Polyunsaturated Fatty Acids (PUFAs) Market Report Scope
This global report on Omega-3 Polyunsaturated Fatty Acids (PUFAs) analyzes the global and regional markets for types (based on raw material source) and end-use applications from 2021-2030 period with projections from 2024 to 2030 in terms of volume shipments in metric tons and value in US$. In addition to providing profiles of major companies operating in this space, the latest corporate and industrial developments have been covered to offer a clear panorama of the industry.
Key Metrics
Historical Period: 2021-2023
Base Year: 2024
Forecast Period: 2024-2030
Units: Volume consumption in Metric Tons and Value market in US$
Companies Mentioned: 140+
Global Omega-3 Polyunsaturated Fatty Acids (PUFAs) Market by Geographic Region
Omega-3 Polyunsaturated Fatty Acids (PUFAs) are widely recognized for their considerable health benefits. They play a crucial role in promoting cardiovascular health and are also associated with protective effects against a variety of health conditions, including cancer, birth defects, diabetes, arthritis, cognitive decline, depression, and several others. These essential fatty acids are not produced by the body in sufficient quantities and must be obtained through diet or supplements. Historically, fish oils have been the primary source for extracting Omega-3 fatty acids, particularly the long-chain varieties like EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid). However, in recent years, attention has increasingly turned toward alternative sources such as krill oil, squid oil, and oils derived from microalgae. Among these, microalgae have emerged as a particularly promising and sustainable source.
The global Omega-3 PUFA ingredients market faced a tumultuous year in 2023. The market experienced pronounced volatility, largely due to significant disruptions in supply and mounting economic challenges. One of the key contributing factors was a marked decline in fish oil production, especially in Peru, which is among the world's leading suppliers. This decline was brought on by a combination of environmental and regulatory factors. The El Nino phenomenon caused shifts in ocean temperatures and altered fish migration patterns, which resulted in lower fish populations. In response, the Peruvian government not only canceled a fishing season but also imposed reduced quotas for allowable catch. These developments, coupled with broader issues such as disruptions in global supply chains, shortages of raw materials, and escalating transportation costs, severely curtailed the availability of Omega-3 ingredients and triggered a significant rise in prices.
Moving into 2024, market conditions began to stabilize. There was an improvement in fishing quotas and a recovery in fish oil production, particularly in regions affected during the previous year. These developments helped to normalize both supply and pricing levels across the market. As a result, global Omega-3 demand registered a growth of 3.8%. However, with prices softening from the elevated levels of 2023, the market's overall value declined by 9.7%, settling at US$2.23 billion. Continued interest in the health benefits of Omega-3s, combined with increasing consumer awareness and innovation in sourcing and product formulation, is expected to support ongoing growth. By the year 2030, global Omega-3 PUFAs demand is projected to reach US$2.54 billion with a compound annual growth rate (CAGR) of 2.4% over the forecast period spanning 2024 to 2030.
Omega-3 Polyunsaturated Fatty Acids (PUFAs) Regional Market Analysis
The report reviews, analyzes and projects the Omega-3 PUFAs market for global and the regional markets including North America, Europe, Asia-Pacific, South America and Rest of World for the period 2021-2030 in terms of volume (metric tons) as well as value (USD). Asia-Pacific region leads the global Omega-3 PUFAs volume market with a share of 41.7% in 2024 and is further projected to record the world fastest CAGR of 5.5% during 2024-2030 to reach 91 thousand metric tons by 2030. In terms of value, North America and Asia-Pacific led the global market with shares of 33.5% and 33.2% respectively in 2024. However, demand for Omega-3 PUFAs in North America is projected to sustain the slowest CAGR of 2.2% during the similar period.
Omega-3 Polyunsaturated Fatty Acids (PUFAs) Market Analysis by Raw Material Source
Omega-3 Polyunsaturated Fatty Acid (PUFAs) ingredients analyzed in this study include Omega-3 EPA and DHA from marine sources including fish oils, krill oils and squid oils; and algal sources. Marine oils constitute the largest raw material source for Omega-3 PUFAs globally, cornering a volume share estimated at 95% in 2024, valued at US$1.8 billion. However, algal oils are likely to emerge as the faster growing source for Omega-3 PUFAs, reaching a projected US$531.5 million in 2030 by registering a CAGR of 6.6% between 2024 and 2030.
Omega-3 Polyunsaturated Fatty Acids (PUFAs) Market Analysis by End-use Application
End use applications of Omega-3PUFAs covered in this report include dietary supplements, food & beverages, animal nutrition including aqua feed and pet food, infant nutrition, pharmaceuticals and clinical nutrition. In terms of volume, dietary supplements and animal nutrition are the two largest applications for Omega-3s globally cornering shares of 57% and 22.2% respectively in 2024. Dietary supplements again lead the value market for Omega-3 globally with US$777 million, followed by infant nutrition and pharmaceuticals in 2024. Demand for Omega-3 PUFAs in the global infant nutrition sector is projected to post the fastest 2024-2030 CAGR of 6.3% in terms of volume, reaching 20 thousand metric tons by 2030.
Omega-3 Polyunsaturated Fatty Acids (PUFAs) Market Report Scope
This global report on Omega-3 Polyunsaturated Fatty Acids (PUFAs) analyzes the global and regional markets for types (based on raw material source) and end-use applications from 2021-2030 period with projections from 2024 to 2030 in terms of volume shipments in metric tons and value in US$. In addition to providing profiles of major companies operating in this space, the latest corporate and industrial developments have been covered to offer a clear panorama of the industry.
Key Metrics
Historical Period: 2021-2023
Base Year: 2024
Forecast Period: 2024-2030
Units: Volume consumption in Metric Tons and Value market in US$
Companies Mentioned: 140+
Global Omega-3 Polyunsaturated Fatty Acids (PUFAs) Market by Geographic Region
- North America (The United States, Canada and Mexico)
- Europe (Germany, France, Italy, Spain, Norway, Denmark, the United Kingdom and Rest of Europe)
- Asia-Pacific (Australia/New Zealand, China, Japan, South Korea, India and Rest of Asia-Pacific)
- South America (Argentina, Brazil and Rest of South America)
- Rest of World
- Marine Oil Sourced Omega-3 PUFAs (EPA and DHA containing Fish Oils, Krill Oils and Squid Oils)
- Algal Oil Sourced Omega-3 PUFAs
- Dietary Supplements
- Food and Beverage Fortification
- Pet Nutrition
- Infant Nutrition
- Pharmaceuticals
- Clinical Nutrition
PART A: GLOBAL MARKET PERSPECTIVE
1. INTRODUCTION
Product Outline
What is Omega-3?
Fatty Acids
Saturated Fatty Acids
Unsaturated Fatty Acids
Polyunsaturated Fatty Acids (PUFAs)
Omega-3 Fatty Acids
Categories of Omega-3 Fatty Acids
Short Chain Omega-3 Fatty Acids
Alpha-Linolenic Acid (ALA)
Long Chain Omega-3 Fatty Acids (LC-PUFAs)
Docosahexaenoic Acid (DHA)
Eicosapentaenoic Acid (EPA)
Dietary Sources of Omega-3 Fatty Acids
Omega-3 and Its Health Benefits
High Cholesterol
High Blood Pressure
Heart Disease
Diabetes
Rheumatoid Arthritis (RA)
Systemic Lupus Erythematosus (SLE)
Osteoporosis
Depression
Bipolar Disorder
Schizophrenia
Attention Deficit/Hyperactivity Disorder (ADHD)
Cognitive Decline
Skin Disorders
Inflammatory Bowel Disease (IBD)
Asthma
Macular Degeneration
Menstrual Pain
Colon Cancer
Breast Cancer
Prostate Cancer
Evolution of Raw Material Sources for Omega-3 Polyunsaturated Fatty Acids (PUFAs)
Marine Oils
Fish Oil
Krill Oil
Other Marine Sources
Algae
Plants
To Conclude
Evolution of Omega-3 Fatty Acid Ingredient Forms
First Generation Omega-3 Forms
Second Generation Omega-3 Forms
Third Generation Omega-3 Forms
Omega-3 PUFA Ingredient Type Analysis
18/12 (30% Omega-3) Fish Oils
Cod Liver Oils
Tuna Oils
Salmon Oils
Omega-3 Low Concentrate (40% to 55%) PUFAs
Omega-3 Medium Concentrate (60% to 80%) PUFAs
Omega-3 High Concentrate (above 85%) PUFAs
Krill Omega-3
Algal Omega-3
Other Omega-3 PUFAs
Omega-3 PUFA End-Use Application Analysis
Dietary Supplements
Animal Nutrition
Food & Beverages
Infant Nutrition
Pharmaceuticals
Clinical Nutrition
Manufacturing Processes for Omega-3 Fatty Acids
Chemistry of Omega-3 Fatty Acids
Processing of Fish Oils
Decontamination
Concentration Process
Production Technologies used for Omega-3 Fatty Acid Concentrates
Chromatographic Methods
Distillation Method
Molecular Distillation (MD)
Low-Temperature Crystallization
Urea Complexation/Precipitation
Enzymatic Methods
Lipase-Catalyzed Hydrolysis
Lipase-Catalyzed Esterification
Supercritical Fluid Technology (SFT)
Supercritical Fluid Extraction (SFE)
Supercritical Fluid Chromatography (SFC)
Microalgae Production
Microalgae as Sources of n-3 LC-PUFA
Algae Oil Extraction
In Conclusion
2. REGULATORY LANDSCAPE FOR OMEGA-3 FATTY ACIDS WORLDWIDE
Recommendations for Omega-3 Fatty Acids (EPA and DHA) Intake
Health Claim Approvals
FDA Approved Health Claims
EFSA Approved Health Claims
Approved Health Claims in Other Regions
Canada
Australia and New Zealand
Japan
Pharmaceutical Omega-3 Drugs Approvals
Regulations and Standards for Fish oils
3. KEY MARKET TRENDS
Strong Outlook for High-Concentration Omega-3s Driven by Rising Pharma and Supplement Use
Docosapentaenoic Acid (DPA) Returns to the Spotlight in Omega-3 Fatty Acid Market
Algae Sources Offer Immense Scope for Global Omega-3s Market
Algae-Based DHA Powers Sustainable Baby Milk: Immense Growth Ahead in Infant Formula Market for Omega-3 PUFAs
4. KEY GLOBAL PLAYERS
Aker Biomarine AA
Archer Daniels Midland Company
Austral Group S.A.A.
Axplora Group GmbH
BASF SE
Berg Lipidtech AS (BLT)
Cellana LLC
Chemport, Inc.
Croda International Plc
DSM-Firmenich AG
Epax AS
Evonik Industries AG
GC Rieber VivoMega AS
Golden Omega SA
Guangdong Runke Bioengineering Co Ltd
Huatai Biopharm Inc.
Jiangsu Auqi Marine Biotechnology Co., Ltd.
KD Pharma Group SA
LYSI hf.
Nippon Suisan Kaisha, Ltd. (NISSUI)
OLVEA Omega Solutions (Olvea Group)
Omega Protein Corporation
Orkla ASA
POLARIS
Qualitas Health Inc. dba iwi
Seven Seas Ltd
Sinomega Biotech Engineering Co Ltd
Solutex GC, S.L.
Stepan Company
Tasa Omega SA
Thai Union Group PCL
Wiley Companies
5. KEY BUSINESS AND PRODUCT TRENDS
Icelandirect Partners with Rbionutrix
Innovaoleo Unveils New Product Omega 3 Star
GC Rieber Vivo Mega to Unveil VivoSense and VivoTech at Expo West 2025
Wiley Companies Re-launches AlaskOmega Omega-7 at Natural Products Expo West 2025
GC Rieber VivoMega Launches new Algae 1060 TG Premium
Arctic Biosciences and Kotler Establish Joint Venture to Target China and other SE Asian markets
Revolutionary Boost in Sustainable Omega-3 Production from Algae
Xinhua Pharmaceutical to Acquire NovoSana Taicang
Above is the partial list, additional developments included in the report
6. GLOBAL MARKET OVERVIEW
Global Omega-3 PUFAs Market Overview by End-use Application
Volume Analysis
Value Analysis
Global Omega-3 PUFAs End-use Application Market Overview by Geographic Region
Dietary Supplements
Volume Analysis
Value Analysis
Animal Nutrition
Volume Analysis
Value Analysis
Food & Beverages
Volume Analysis
Value Analysis
Infant Nutrition
Volume Analysis
Value Analysis
Pharmaceuticals
Volume Analysis
Value Analysis
Clinical Nutrition
Volume Analysis
Value Analysis
Global Omega-3 PUFAs Market Overview by Raw Material Source
Volume Analysis
Value Analysis
Global Omega-3 PUFAs Raw Material Source Market Overview by Geographic Region
Marine Omega-3 PUFAs
Volume Analysis
Value Analysis
Algal Omega-3 PUFAs
Volume Analysis
Value Analysis
Global Omega-3 PUFAs Market Overview by Ingredient Type
Volume Analysis
Value Analysis
PART B: REGIONAL MARKET PERSPECTIVE
Global Omega-3 PUFAs Market Overview by Geographic Region
Volume Analysis
Value Analysis
REGIONAL MARKET OVERVIEW
7. NORTH AMERICA
North American Omega-3 PUFAs Market Overview by Geographic Region
Volume Analysis
Value Analysis
North American Omega-3 PUFAs Market Overview by Raw Material Source
Volume Analysis
Value Analysis
North American Omega-3 PUFAs Market Overview by End-Use Application
Volume Analysis
Value Analysis
Major Market Players
Aker BioMarine Manufacturing LLC (United States)
Algae to Omega (United States)
Algisys, LLC (United States)
Archer Daniels Midland Company (United States)
ArcticSource1 LLC (United States)
Arizona Algae Products, LLC (United States)
Bering Select LLC (United States)
Bioriginal (Canada)
CAS BioSciences, LLC (United States)
Cellana LLC (United States)
Corbion, Inc. (United States)
GCI Nutrients, Inc. (United States)
Helios Corp (United States)
Mara Renewables Corporation (Canada)
Algarithm Ingredients, Inc. (Canada)
Nordic Naturals, Inc. (United States)
Novotech Nutraceuticals, Inc. (United States)
Omega Protein Corporation (United States)
Originates Inc. (United States)
Pure Alaska Omega (United States)
Qualitas Health Inc. dba iwi (UNITED STATES)
Rimfrost AS (Norway)
Solarvest Bioenergy Inc. (Canada)
Source-Omega LLC (United States)
SourceOne Global Partners (United States)
Stepan Company (United States)
The Wright Group (United States)
Virun, Inc. (United States)
Wiley Companies (United States)
8. EUROPE
European Omega-3 PUFAs Market Overview by Geographic Region
Volume Analysis
Value Analysis
European Omega-3 PUFAs Market Overview by Raw Material Source
Volume Analysis
Value Analysis
European Omega-3 PUFAs Market Overview by End-Use Application
Volume Analysis
Value Analysis
Major Market Players
Aker Biomarine AS (Norway)
Algae Capital B.V. (Netherlands)
AlgaeCytes Limited (United Kingdom)
Anklam Extrakt GmbH (Germany)
Arctic Bioscience AS (Norway)
Axplora Group GmbH (Germany)
BASF SE (Germany)
Berg Lipidtech AS (BLT) (Norway)
Bluebiotech International GmbH (Germany)
Brudy Technology S.L. (Spain)
Carniolus d.o.o. (Slovenia)
Copalis (France)
Croda International Plc (United Kingdom)
De Wit Speciality Oils (Netherlands)
Denomega (Orkla Health) (Norway)
DSM-Firmenich AG (Switzerland)
Epax AS (Norway)
Evonik Industries AG (Germany)
Fermentalg SA (France)
Fortuna Oils AS (Norway)
GC Rieber Oils (Norway)
Grontvedt Biotech (Norway)
Henry Lamotte Oils GmbH (Germany)
Hofseth Biocare AS (Norway)
Huve Nutraceutical Ltd (Bulgaria)
Impact Ingredients BV (Netherlands)
Imperial-Oel-Import Handelsgesellschaft mbh (Germany)
IQI B.V. (Netherlands)
KD Pharma Group SA (Switzerland)
Kerry Group plc (Ireland)
LYSI hf. (Iceland)
Margildi EHF. (Iceland)
Minami Nutrition (Belgium)
Mowi ASA (NORWAY)
Natac Natural Ingredients S.L.U. - Innovaoleo (Spain)
Noble Harvest AS (Norway)
Norwegian Fish Oil AS (Norway)
Nutriswiss AG (Switzerland)
OLVEA Omega Solutions (OLVEA Group) (France)
Omnipharm SAS (France)
Pharma Marine AS (Norway)
POLARIS (France)
Progress Biotech bv (Netherlands)
Rimfrost AS (Norway)
Seafoodia (France)
SEANOVA (France)
Seven Seas Ltd (United Kingdom)
Simris Alg AB (Sweden)
Sochim International Spa (Italy)
Solutex GC, S.L. (Spain)
Stepan Lipid Nutrition (Netherlands)
Thai Union Marine Nutrients GmbH (Germany)
Triplenine Group A/S (Denmark)
True Westfjords ehf (Iceland)
Veramaris V.O.F. (Netherlands)
Vesteraalens AS (Norway)
Zooca (Norway)
9. ASIA-PACIFIC
Asia-Pacific Omega-3 PUFAs Market Overview by Geographic Region
Volume Analysis
Value Analysis
Asia-Pacific Omega-3 PUFAs Market Overview by Raw Material Source
Volume Analysis
Value Analysis
Asia-Pacific Omega-3 PUFAs Market Overview by End-Use Application
Volume Analysis
Value Analysis
Major Market Players
AK & MN BioFarm Co Ltd (South Korea)
Ambe Phytoextracts Pvt. Ltd. (India)
Arbee Biomarine Extracts Pvt Ltd. (India)
Arjuna Natural Pvt Ltd (India)
ATK Biotech Co., Ltd. (China)
Avesthagen Limited (India)
BioPlus life Sciences Pvt. Ltd. (India)
Bizen Chemical Co Ltd (Japan)
Blueline Foods (India) Pvt Ltd (India)
CABIO Biotech (Wuhan) Co., Ltd. (China)
Camlin Fine Sciences, Ltd. (India)
Chambio Co., Ltd. (Taiwan)
Chemport, Inc. (South Korea)
Clover Corporation (Nu-Mega) (Australia)
Coastal Exports Corporation (India)
ECA Healthcare Inc (China)
Ennature Biopharma (India Glycols Ltd) (India)
Fenchem Biotek Ltd (China)
Fujian High Fortune Bio-Tech Corp. (China)
Guangdong Runke Bioengineering Co Ltd (China)
Huatai Biopharm Inc. (China)
Hubei Fuxing Biotechnology Co Ltd (China)
Jiangsu Auqi Marine Biotechnology Co., Ltd. (China)
Jiangsu Weisikang Food Sci-tech Development Co., Ltd. (China)
K Pharmtech Co. Ltd. (South Korea)
Kangcare Bioindustry Co., Ltd. (China)
Kinomega Biopharm Inc. (China)
Luhua Biomarine (Shandong) Co., Ltd (China)
Nippon Suisan Kaisha, Ltd. (NISSUI) (Japan)
Nisshin Pharma Inc. (Japan)
Novosana (Taicang) Co. Ltd. (China)
Phycoil Biotech Korea, Inc. (South Korea)
Qingdao AlgaeNutra Biotech Co., Ltd (China)
Qponics Limited (Australia)
Seadragon Marine Oils Ltd (New Zealand)
Shandong Yuwang Pharmaceutical Co., Ltd (China)
Shangdong Kangjing Marine Biotechnology Co., Ltd (China)
Shenzhen Qianhai Xiaozao Technology Ltd.(Lyxia) (China)
Sinomega Biotech Engineering Co Ltd (China)
Skuny Bioscience Co., Ltd. (China)
Thai Union Group PCL (Thailand)
Wuxi Xunda Marine Biological Products Co., Ltd. (China)
Xiamen Huison Biotech Co., Ltd. (China)
ZhongHai Ocean Technology Co., Ltd. (China)
10. SOUTH AMERICA
South American Omega-3 PUFAs Market Overview by Geographic Region
Volume Analysis
Value Analysis
South American Omega-3 PUFAs Market Overview by Raw Material Source
Volume Analysis
Value Analysis
South American Omega-3 PUFAs Market Overview by End-Use Application
Volume Analysis
Value Analysis
Major Market Players
AntarcticOmega SpA (Chile)
Austral Group S.A.A. (Peru)
Colpex International S.A.C (Peru)
Corporacion Pesquera Inca S.A.C. (Peru)
Cox & Compania S.A. (Chile)
GIHON - Laboratorios QuImicos SRL (Argentina)
Golden Omega SA (Chile)
Natural Oils Chile SA (Chile)
Naturmega SA (Colombia)
Pesquera Camanchaca SA (Chile)
Pesquera Diamante SA (Peru)
Pesquera Hayduk SA (Peru)
SPES S.A. (Chile)
TASA Omega SA (Tecnologica De Alimentos SA) (Peru)
11. REST OF WORLD
Rest of World Omega-3 PUFAs Market Overview by Raw Material Source
Volume Analysis
Value Analysis
Rest of World Omega-3 PUFAs Market Overview by End-Use Application
Volume Analysis
Value Analysis
Major Market Player
Rbionutrix FZ LLC (United Arab Emirates)
12. OMEGA-3 PATENT LANDSCAPE
Fish Oil Omega-3 Fatty Acids
Algal Oil Omega-3 Fatty Acids
PART C: GUIDE TO THE INDUSTRY
Manufacturers of Omega 3 Ingredients
Raw Material Producers and Equipment Suppliers
Major Ingredient Distributors
Omega-3 End-users
PART D: ANNEXURE
RESEARCH METHODOLOGY
FEEDBACK
1. INTRODUCTION
Product Outline
What is Omega-3?
Fatty Acids
Saturated Fatty Acids
Unsaturated Fatty Acids
Polyunsaturated Fatty Acids (PUFAs)
Omega-3 Fatty Acids
Categories of Omega-3 Fatty Acids
Short Chain Omega-3 Fatty Acids
Alpha-Linolenic Acid (ALA)
Long Chain Omega-3 Fatty Acids (LC-PUFAs)
Docosahexaenoic Acid (DHA)
Eicosapentaenoic Acid (EPA)
Dietary Sources of Omega-3 Fatty Acids
Omega-3 and Its Health Benefits
High Cholesterol
High Blood Pressure
Heart Disease
Diabetes
Rheumatoid Arthritis (RA)
Systemic Lupus Erythematosus (SLE)
Osteoporosis
Depression
Bipolar Disorder
Schizophrenia
Attention Deficit/Hyperactivity Disorder (ADHD)
Cognitive Decline
Skin Disorders
Inflammatory Bowel Disease (IBD)
Asthma
Macular Degeneration
Menstrual Pain
Colon Cancer
Breast Cancer
Prostate Cancer
Evolution of Raw Material Sources for Omega-3 Polyunsaturated Fatty Acids (PUFAs)
Marine Oils
Fish Oil
Krill Oil
Other Marine Sources
Algae
Plants
To Conclude
Evolution of Omega-3 Fatty Acid Ingredient Forms
First Generation Omega-3 Forms
Second Generation Omega-3 Forms
Third Generation Omega-3 Forms
Omega-3 PUFA Ingredient Type Analysis
18/12 (30% Omega-3) Fish Oils
Cod Liver Oils
Tuna Oils
Salmon Oils
Omega-3 Low Concentrate (40% to 55%) PUFAs
Omega-3 Medium Concentrate (60% to 80%) PUFAs
Omega-3 High Concentrate (above 85%) PUFAs
Krill Omega-3
Algal Omega-3
Other Omega-3 PUFAs
Omega-3 PUFA End-Use Application Analysis
Dietary Supplements
Animal Nutrition
Food & Beverages
Infant Nutrition
Pharmaceuticals
Clinical Nutrition
Manufacturing Processes for Omega-3 Fatty Acids
Chemistry of Omega-3 Fatty Acids
Processing of Fish Oils
Decontamination
Concentration Process
Production Technologies used for Omega-3 Fatty Acid Concentrates
Chromatographic Methods
Distillation Method
Molecular Distillation (MD)
Low-Temperature Crystallization
Urea Complexation/Precipitation
Enzymatic Methods
Lipase-Catalyzed Hydrolysis
Lipase-Catalyzed Esterification
Supercritical Fluid Technology (SFT)
Supercritical Fluid Extraction (SFE)
Supercritical Fluid Chromatography (SFC)
Microalgae Production
Microalgae as Sources of n-3 LC-PUFA
Algae Oil Extraction
In Conclusion
2. REGULATORY LANDSCAPE FOR OMEGA-3 FATTY ACIDS WORLDWIDE
Recommendations for Omega-3 Fatty Acids (EPA and DHA) Intake
Health Claim Approvals
FDA Approved Health Claims
EFSA Approved Health Claims
Approved Health Claims in Other Regions
Canada
Australia and New Zealand
Japan
Pharmaceutical Omega-3 Drugs Approvals
Regulations and Standards for Fish oils
3. KEY MARKET TRENDS
Strong Outlook for High-Concentration Omega-3s Driven by Rising Pharma and Supplement Use
Docosapentaenoic Acid (DPA) Returns to the Spotlight in Omega-3 Fatty Acid Market
Algae Sources Offer Immense Scope for Global Omega-3s Market
Algae-Based DHA Powers Sustainable Baby Milk: Immense Growth Ahead in Infant Formula Market for Omega-3 PUFAs
4. KEY GLOBAL PLAYERS
Aker Biomarine AA
Archer Daniels Midland Company
Austral Group S.A.A.
Axplora Group GmbH
BASF SE
Berg Lipidtech AS (BLT)
Cellana LLC
Chemport, Inc.
Croda International Plc
DSM-Firmenich AG
Epax AS
Evonik Industries AG
GC Rieber VivoMega AS
Golden Omega SA
Guangdong Runke Bioengineering Co Ltd
Huatai Biopharm Inc.
Jiangsu Auqi Marine Biotechnology Co., Ltd.
KD Pharma Group SA
LYSI hf.
Nippon Suisan Kaisha, Ltd. (NISSUI)
OLVEA Omega Solutions (Olvea Group)
Omega Protein Corporation
Orkla ASA
POLARIS
Qualitas Health Inc. dba iwi
Seven Seas Ltd
Sinomega Biotech Engineering Co Ltd
Solutex GC, S.L.
Stepan Company
Tasa Omega SA
Thai Union Group PCL
Wiley Companies
5. KEY BUSINESS AND PRODUCT TRENDS
Icelandirect Partners with Rbionutrix
Innovaoleo Unveils New Product Omega 3 Star
GC Rieber Vivo Mega to Unveil VivoSense and VivoTech at Expo West 2025
Wiley Companies Re-launches AlaskOmega Omega-7 at Natural Products Expo West 2025
GC Rieber VivoMega Launches new Algae 1060 TG Premium
Arctic Biosciences and Kotler Establish Joint Venture to Target China and other SE Asian markets
Revolutionary Boost in Sustainable Omega-3 Production from Algae
Xinhua Pharmaceutical to Acquire NovoSana Taicang
Above is the partial list, additional developments included in the report
6. GLOBAL MARKET OVERVIEW
Global Omega-3 PUFAs Market Overview by End-use Application
Volume Analysis
Value Analysis
Global Omega-3 PUFAs End-use Application Market Overview by Geographic Region
Dietary Supplements
Volume Analysis
Value Analysis
Animal Nutrition
Volume Analysis
Value Analysis
Food & Beverages
Volume Analysis
Value Analysis
Infant Nutrition
Volume Analysis
Value Analysis
Pharmaceuticals
Volume Analysis
Value Analysis
Clinical Nutrition
Volume Analysis
Value Analysis
Global Omega-3 PUFAs Market Overview by Raw Material Source
Volume Analysis
Value Analysis
Global Omega-3 PUFAs Raw Material Source Market Overview by Geographic Region
Marine Omega-3 PUFAs
Volume Analysis
Value Analysis
Algal Omega-3 PUFAs
Volume Analysis
Value Analysis
Global Omega-3 PUFAs Market Overview by Ingredient Type
Volume Analysis
Value Analysis
PART B: REGIONAL MARKET PERSPECTIVE
Global Omega-3 PUFAs Market Overview by Geographic Region
Volume Analysis
Value Analysis
REGIONAL MARKET OVERVIEW
7. NORTH AMERICA
North American Omega-3 PUFAs Market Overview by Geographic Region
Volume Analysis
Value Analysis
North American Omega-3 PUFAs Market Overview by Raw Material Source
Volume Analysis
Value Analysis
North American Omega-3 PUFAs Market Overview by End-Use Application
Volume Analysis
Value Analysis
Major Market Players
Aker BioMarine Manufacturing LLC (United States)
Algae to Omega (United States)
Algisys, LLC (United States)
Archer Daniels Midland Company (United States)
ArcticSource1 LLC (United States)
Arizona Algae Products, LLC (United States)
Bering Select LLC (United States)
Bioriginal (Canada)
CAS BioSciences, LLC (United States)
Cellana LLC (United States)
Corbion, Inc. (United States)
GCI Nutrients, Inc. (United States)
Helios Corp (United States)
Mara Renewables Corporation (Canada)
Algarithm Ingredients, Inc. (Canada)
Nordic Naturals, Inc. (United States)
Novotech Nutraceuticals, Inc. (United States)
Omega Protein Corporation (United States)
Originates Inc. (United States)
Pure Alaska Omega (United States)
Qualitas Health Inc. dba iwi (UNITED STATES)
Rimfrost AS (Norway)
Solarvest Bioenergy Inc. (Canada)
Source-Omega LLC (United States)
SourceOne Global Partners (United States)
Stepan Company (United States)
The Wright Group (United States)
Virun, Inc. (United States)
Wiley Companies (United States)
8. EUROPE
European Omega-3 PUFAs Market Overview by Geographic Region
Volume Analysis
Value Analysis
European Omega-3 PUFAs Market Overview by Raw Material Source
Volume Analysis
Value Analysis
European Omega-3 PUFAs Market Overview by End-Use Application
Volume Analysis
Value Analysis
Major Market Players
Aker Biomarine AS (Norway)
Algae Capital B.V. (Netherlands)
AlgaeCytes Limited (United Kingdom)
Anklam Extrakt GmbH (Germany)
Arctic Bioscience AS (Norway)
Axplora Group GmbH (Germany)
BASF SE (Germany)
Berg Lipidtech AS (BLT) (Norway)
Bluebiotech International GmbH (Germany)
Brudy Technology S.L. (Spain)
Carniolus d.o.o. (Slovenia)
Copalis (France)
Croda International Plc (United Kingdom)
De Wit Speciality Oils (Netherlands)
Denomega (Orkla Health) (Norway)
DSM-Firmenich AG (Switzerland)
Epax AS (Norway)
Evonik Industries AG (Germany)
Fermentalg SA (France)
Fortuna Oils AS (Norway)
GC Rieber Oils (Norway)
Grontvedt Biotech (Norway)
Henry Lamotte Oils GmbH (Germany)
Hofseth Biocare AS (Norway)
Huve Nutraceutical Ltd (Bulgaria)
Impact Ingredients BV (Netherlands)
Imperial-Oel-Import Handelsgesellschaft mbh (Germany)
IQI B.V. (Netherlands)
KD Pharma Group SA (Switzerland)
Kerry Group plc (Ireland)
LYSI hf. (Iceland)
Margildi EHF. (Iceland)
Minami Nutrition (Belgium)
Mowi ASA (NORWAY)
Natac Natural Ingredients S.L.U. - Innovaoleo (Spain)
Noble Harvest AS (Norway)
Norwegian Fish Oil AS (Norway)
Nutriswiss AG (Switzerland)
OLVEA Omega Solutions (OLVEA Group) (France)
Omnipharm SAS (France)
Pharma Marine AS (Norway)
POLARIS (France)
Progress Biotech bv (Netherlands)
Rimfrost AS (Norway)
Seafoodia (France)
SEANOVA (France)
Seven Seas Ltd (United Kingdom)
Simris Alg AB (Sweden)
Sochim International Spa (Italy)
Solutex GC, S.L. (Spain)
Stepan Lipid Nutrition (Netherlands)
Thai Union Marine Nutrients GmbH (Germany)
Triplenine Group A/S (Denmark)
True Westfjords ehf (Iceland)
Veramaris V.O.F. (Netherlands)
Vesteraalens AS (Norway)
Zooca (Norway)
9. ASIA-PACIFIC
Asia-Pacific Omega-3 PUFAs Market Overview by Geographic Region
Volume Analysis
Value Analysis
Asia-Pacific Omega-3 PUFAs Market Overview by Raw Material Source
Volume Analysis
Value Analysis
Asia-Pacific Omega-3 PUFAs Market Overview by End-Use Application
Volume Analysis
Value Analysis
Major Market Players
AK & MN BioFarm Co Ltd (South Korea)
Ambe Phytoextracts Pvt. Ltd. (India)
Arbee Biomarine Extracts Pvt Ltd. (India)
Arjuna Natural Pvt Ltd (India)
ATK Biotech Co., Ltd. (China)
Avesthagen Limited (India)
BioPlus life Sciences Pvt. Ltd. (India)
Bizen Chemical Co Ltd (Japan)
Blueline Foods (India) Pvt Ltd (India)
CABIO Biotech (Wuhan) Co., Ltd. (China)
Camlin Fine Sciences, Ltd. (India)
Chambio Co., Ltd. (Taiwan)
Chemport, Inc. (South Korea)
Clover Corporation (Nu-Mega) (Australia)
Coastal Exports Corporation (India)
ECA Healthcare Inc (China)
Ennature Biopharma (India Glycols Ltd) (India)
Fenchem Biotek Ltd (China)
Fujian High Fortune Bio-Tech Corp. (China)
Guangdong Runke Bioengineering Co Ltd (China)
Huatai Biopharm Inc. (China)
Hubei Fuxing Biotechnology Co Ltd (China)
Jiangsu Auqi Marine Biotechnology Co., Ltd. (China)
Jiangsu Weisikang Food Sci-tech Development Co., Ltd. (China)
K Pharmtech Co. Ltd. (South Korea)
Kangcare Bioindustry Co., Ltd. (China)
Kinomega Biopharm Inc. (China)
Luhua Biomarine (Shandong) Co., Ltd (China)
Nippon Suisan Kaisha, Ltd. (NISSUI) (Japan)
Nisshin Pharma Inc. (Japan)
Novosana (Taicang) Co. Ltd. (China)
Phycoil Biotech Korea, Inc. (South Korea)
Qingdao AlgaeNutra Biotech Co., Ltd (China)
Qponics Limited (Australia)
Seadragon Marine Oils Ltd (New Zealand)
Shandong Yuwang Pharmaceutical Co., Ltd (China)
Shangdong Kangjing Marine Biotechnology Co., Ltd (China)
Shenzhen Qianhai Xiaozao Technology Ltd.(Lyxia) (China)
Sinomega Biotech Engineering Co Ltd (China)
Skuny Bioscience Co., Ltd. (China)
Thai Union Group PCL (Thailand)
Wuxi Xunda Marine Biological Products Co., Ltd. (China)
Xiamen Huison Biotech Co., Ltd. (China)
ZhongHai Ocean Technology Co., Ltd. (China)
10. SOUTH AMERICA
South American Omega-3 PUFAs Market Overview by Geographic Region
Volume Analysis
Value Analysis
South American Omega-3 PUFAs Market Overview by Raw Material Source
Volume Analysis
Value Analysis
South American Omega-3 PUFAs Market Overview by End-Use Application
Volume Analysis
Value Analysis
Major Market Players
AntarcticOmega SpA (Chile)
Austral Group S.A.A. (Peru)
Colpex International S.A.C (Peru)
Corporacion Pesquera Inca S.A.C. (Peru)
Cox & Compania S.A. (Chile)
GIHON - Laboratorios QuImicos SRL (Argentina)
Golden Omega SA (Chile)
Natural Oils Chile SA (Chile)
Naturmega SA (Colombia)
Pesquera Camanchaca SA (Chile)
Pesquera Diamante SA (Peru)
Pesquera Hayduk SA (Peru)
SPES S.A. (Chile)
TASA Omega SA (Tecnologica De Alimentos SA) (Peru)
11. REST OF WORLD
Rest of World Omega-3 PUFAs Market Overview by Raw Material Source
Volume Analysis
Value Analysis
Rest of World Omega-3 PUFAs Market Overview by End-Use Application
Volume Analysis
Value Analysis
Major Market Player
Rbionutrix FZ LLC (United Arab Emirates)
12. OMEGA-3 PATENT LANDSCAPE
Fish Oil Omega-3 Fatty Acids
Algal Oil Omega-3 Fatty Acids
PART C: GUIDE TO THE INDUSTRY
Manufacturers of Omega 3 Ingredients
Raw Material Producers and Equipment Suppliers
Major Ingredient Distributors
Omega-3 End-users
PART D: ANNEXURE
RESEARCH METHODOLOGY
FEEDBACK
The past several decades have been witness to research studies that have underscored the significance of omega-3 fatty acids in maintaining heart health, in addition to safeguarding against cancer and birth defects and offsetting symptoms of diabetes, arthritis, cognitive decline, depression and several other conditions.
Omega-3 Polyunsatuarated Fatty Acids (PUFAs) have been growing and continues to grow significantly in the future, attributed to the above benefits.
There are many contributing factors that may influence the omega-3s market in the future. Though the predominance of fish oil in the global market for omega-3 has been driving the market and would continue to do so, the scenario of the future is likely to depict a contrasting picture. For one, the market has been witnessing a marked shift towards products with higher concentrations, a trend that has been more conspicuous in the developing world. This has been the consequence of consumers upgrading from lower concentrate products to higher concentrate products in a bid to get more EPA/DHA per capsule or softgel.
Products with higher concentrations offer the benefit of obtaining the similar health promoting levels of EPA and DHA, though in smaller or fewer capsules or softgels.
Pharmaceutical drugs, by default, have started incorporating higher concentrations of omega-3 and it is anticipated that, over the coming few years, several new companies would be jumping on to the bandwagon of omega-3 drugs. Several drugs are in Phase II or Phase III clinical trials, with several more expected to come on-stream quite soon. However, the coming year or two is likely to witness an influx of new companies invading the global omega-3 market, provided they obtain the USFDA’s or other relevant authorities’ approvals.
In a global scenario where increasing attention is being directed towards issues of sustainability and limited food supplies, algal sources offer immense scope for the rapidly expanding omega-3 market to continue in the same vein. The focus on obtaining EPA and DHA from algae was prompted by an endeavor to seek out more sustainable sources, since EPA and DHA are naturally contained in algae. Moreover, the omega-3 content in fish and krill originates from their consuming the algae directly or other creatures that feed on algae. In addition to being sustainable, algae also allows for farming that can be of help in putting up desirable labels, such as “vegetarian,” “kosher” or even “organic.”
Expansion of market access and production capabilities of numerous players in the omega-3 space has been motivated through greater consumer awareness and demand for Omega-3 in triglyceride form. Research has established improved absorption and bioavailability of triglyceride omega-3 when compared to the ethyl ester form. Hence, manufacturers are presented with an unmatched opportunity to address the growing trend evolving from choosing omega-3 triglycerides over ethyl esters, specifically in ultrapure and highly concentrated forms.
On the other side of the coin, specifically in the United States, a negative July 2013 study on omega-3 which connected to prostate cancer risk has hampered the omega-3 market growth. United States omega-3 ingredient sales in second half of the year 2013 in dietary supplement sector has been significantly reduced compared to other application sectors. The impact is believed to be only in the US omega-3 market and there is little bit or no impact observed in Europe and Asia-Pacific regions. Omega-3 industry has been defending and will defend these negative studies in the future and omega-3 sales are expected to be growing as usual in the coming years.
